CN114129489A - 一种紧致皮肤、抑制皮肤黑色素生成的组合物 - Google Patents
一种紧致皮肤、抑制皮肤黑色素生成的组合物 Download PDFInfo
- Publication number
- CN114129489A CN114129489A CN202111664558.6A CN202111664558A CN114129489A CN 114129489 A CN114129489 A CN 114129489A CN 202111664558 A CN202111664558 A CN 202111664558A CN 114129489 A CN114129489 A CN 114129489A
- Authority
- CN
- China
- Prior art keywords
- skin
- parts
- extract
- composition
- tightening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 15
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title abstract description 24
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 16
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 15
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 10
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 claims abstract description 10
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 9
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 9
- 229960000271 arbutin Drugs 0.000 claims abstract description 9
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940064064 purslane extract Drugs 0.000 claims abstract description 9
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 8
- 230000008099 melanin synthesis Effects 0.000 claims abstract 6
- 241000208340 Araliaceae Species 0.000 claims description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 15
- 235000008434 ginseng Nutrition 0.000 claims description 15
- 235000006708 antioxidants Nutrition 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 229940088598 enzyme Drugs 0.000 claims description 10
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 9
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 9
- 235000021283 resveratrol Nutrition 0.000 claims description 9
- 229940016667 resveratrol Drugs 0.000 claims description 9
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 108010059820 Polygalacturonase Proteins 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 4
- 108010024636 Glutathione Proteins 0.000 claims description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical group COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 4
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 4
- 229960003180 glutathione Drugs 0.000 claims description 4
- 235000003969 glutathione Nutrition 0.000 claims description 4
- 235000019136 lipoic acid Nutrition 0.000 claims description 4
- 229960002663 thioctic acid Drugs 0.000 claims description 4
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 230000003061 melanogenesis Effects 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 abstract description 2
- 108010035532 Collagen Proteins 0.000 abstract description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000032823 cell division Effects 0.000 abstract description 2
- 229920001436 collagen Polymers 0.000 abstract description 2
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 abstract description 2
- 230000005012 migration Effects 0.000 abstract description 2
- 238000013508 migration Methods 0.000 abstract description 2
- 230000019612 pigmentation Effects 0.000 abstract description 2
- 230000028327 secretion Effects 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 25
- 230000032683 aging Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种紧致皮肤、抑制皮肤黑色素生成的组合物，组分包括：马齿苋萃取物，β‑葡聚糖，抗氧化物，熊果苷，烟酰胺，红景天素，人参提取物。本发明优点包括：有效补水保湿可以避免皮肤干燥，保持莹润细腻状态，使肌肤通透，有较好的吸收能力；从黑色素生成源头、迁移路径上减少色素沉积；红景天素、人参提取物能重建细胞外基质、促进纤维细胞分裂并促进合成和分泌胶原蛋白，能够预防/减缓肌肤松弛，使肌肤紧致有弹力。
Description
技术领域
本发明涉及一种护肤品，尤其涉及紧致皮肤、抑制黑色素生成的组合物。
背景技术
随着人们生活水平、社交需求提高，对护肤越来越重视。生活方式改变对人体健康造成影响，体内收到影响会呈现在脸上。除了注重内在调养，同时也不可忽视脸部皮肤的保养，才能使人状态达到最佳水平，更使人自信。年龄的增长的确会让人皮肤发生松弛，肤色不均或者产生/加深色斑，但是有效的针对性保养护肤方式会让皮肤延迟衰老，使皮肤紧致、肤色均匀亮泽，防止色斑生长/加深。
发明内容
本发明的目的在于提供一种紧致皮肤、抑制皮肤黑色素生成的组合物，以有效解决皮肤松弛、黑色素产生导致色斑生成/加深的问题。
为了达到上述目的本发明采用如下技术方案：
一种紧致皮肤、抑制皮肤黑色素生成的组合物，按重量份计，包括如下组分：
马齿苋萃取物0.5-2份，β-葡聚糖0.2-1份，抗氧化物2.5-4份，熊果苷0.08-1.5份，烟酰胺0.1-2.5份，红景天素0.3-1.5份，人参提取物1.5-2份。
进一步地，所述按重量份计，包括如下组分：
马齿苋萃取物0.5份，β-葡聚糖1份，抗氧化物4份，熊果苷1份，烟酰胺1.5份，红景天素1份，人参提取物2份。
进一步地，所述抗氧化物选自辅酶Q10、谷胱甘肽、硫辛酸、白藜芦醇、黄岑提取物。
进一步地，所述抗氧化物是白藜芦醇和黄岑提取物。
进一步地，所述人参获取过程是：粉碎人参，然后用酶提取液在60℃酶解4h；再加入水，在95-100℃提取1.5h，浓缩提取液，干燥得到人参提取物。
进一步地，所述酶提取液是纤维素酶和果胶酶的水溶液。
本发明的优点包括：马齿苋萃取物补水，β-葡聚糖保湿可以避免皮肤干燥，保持莹润细腻状态，使肌肤通透，有较好的吸收能力；熊果苷抑制酪氨酸酶活性，以及辅酶Q10、谷胱甘肽、硫辛酸、白藜芦醇、黄岑提取物起到抗氧化效果，减少黑色素生成，尤其使白藜芦醇和黄岑提取物两者协同作用，效果更佳；烟酰胺阻止黑色素从黑色素细胞迁移到角质细胞，阻止色素沉积；红景天素、人参提取物能重建细胞外基质、促进纤维细胞分裂并促进合成和分泌胶原蛋白，能够预防/减缓肌肤松弛，使肌肤紧致有弹力。
具体实施方式
下面将结合具体实施例来详细说明本发明，在此以本发明的示意性实施例及说明用来解释本发明，但并不作为对本发明的限定。
实施例一
一种紧致皮肤、抑制皮肤黑色素生成的组合物，按重量份计，包括如下组分：
马齿苋萃取物0.5份，β-葡聚糖1份，抗氧化物4份，熊果苷1份，烟酰胺1.5份，红景天素1份，人参提取物2份。
所述抗氧化物是白藜芦醇和黄岑提取物。
所述人参获取过程是：粉碎人参，然后用酶提取液在60℃酶解4h；再加入水，在95-100℃提取1.5h，浓缩提取液，干燥得到人参提取物。
所述酶提取液是纤维素酶和果胶酶的水溶液。
实施例二
一种紧致皮肤、抑制皮肤黑色素生成的组合物，按重量份计，包括如下组分：
马齿苋萃取物2份，β-葡聚糖1份，抗氧化物2.5份，熊果苷1.5份，烟酰胺2.5份，红景天素1.5份，人参提取物2份。
所述抗氧化物是白藜芦醇和黄岑提取物。
所述人参获取过程是：粉碎人参，然后用酶提取液在60℃酶解4h；再加入水，在95-100℃提取1.5h，浓缩提取液，干燥得到人参提取物。
所述酶提取液是纤维素酶和果胶酶的水溶液。
实施例三
一种紧致皮肤、抑制皮肤黑色素生成的组合物，按重量份计，包括如下组分：
马齿苋萃取物0.5-2份，β-葡聚糖0.2-1份，抗氧化物2.5-4份，熊果苷0.08-1.5份，烟酰胺0.1-2.5份，红景天素0.3-1.5份，人参提取物1.5-2份。
所述抗氧化物是辅酶Q10、谷胱甘肽、硫辛酸、白藜芦醇、黄岑提取物。
所述人参获取过程是：粉碎人参，然后用酶提取液在60℃酶解4h；再加入水，在95-100℃提取1.5h，浓缩提取液，干燥得到人参提取物。
所述酶提取液是纤维素酶和果胶酶的水溶液。
所述实施例一～三所得的组合物可以结合化妆品、食品、药品上可接受的辅料制备成不同的剂型，比如精华、乳、霜、面膜。
以上对本发明实施例所提供的技术方案进行了详细介绍，本文中应用了具体个例对本发明实施例的原理以及实施方式进行了阐述，以上实施例的说明只适用于帮助理解本发明实施例的原理；同时，对于本领域的一般技术人员，依据本发明实施例，在具体实施方式以及应用范围上均会有改变之处，综上所述，本说明书内容不应理解为对本发明的限制。
Claims (6)
1.一种紧致皮肤、抑制皮肤黑色素生成的组合物，其特征在于：
按重量份计，包括如下组分：
马齿苋萃取物0.5-2份，β-葡聚糖0.2-1份，抗氧化物2.5-4份，熊果苷0.08-1.5份，烟酰胺0.1-2.5份，红景天素0.3-1.5份，人参提取物1.5-2份。
2.根据权利要求1所述的一种紧致皮肤、抑制皮肤黑色素生成的组合物，其特征在于：
所述按重量份计，包括如下组分：
马齿苋萃取物0.5份，β-葡聚糖1份，抗氧化物4份，熊果苷1份，烟酰胺1.5份，红景天素1份，人参提取物2份。
3.根据权利要求2所述的一种紧致皮肤、抑制皮肤黑色素生成的组合物，其特征在于：
所述抗氧化物选自辅酶Q10、谷胱甘肽、硫辛酸、白藜芦醇、黄岑提取物。
4.根据权利要求3所述的一种紧致皮肤、抑制皮肤黑色素生成的组合物，其特征在于：
所述抗氧化物是白藜芦醇和黄岑提取物。
5.根据权利要求1所述的一种紧致皮肤、抑制皮肤黑色素生成的组合物，其特征在于：
所述人参获取过程是：粉碎人参，然后用酶提取液在60℃酶解4h；再加入水，在95-100℃提取1.5h，浓缩提取液，干燥得到人参提取物。
6.根据权利要求5所述的一种紧致皮肤、抑制皮肤黑色素生成的组合物，其特征在于：
所述酶提取液是纤维素酶和果胶酶的水溶液。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111664558.6A CN114129489A (zh) | 2021-12-31 | 2021-12-31 | 一种紧致皮肤、抑制皮肤黑色素生成的组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111664558.6A CN114129489A (zh) | 2021-12-31 | 2021-12-31 | 一种紧致皮肤、抑制皮肤黑色素生成的组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114129489A true CN114129489A (zh) | 2022-03-04 |
Family
ID=80384204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111664558.6A Pending CN114129489A (zh) | 2021-12-31 | 2021-12-31 | 一种紧致皮肤、抑制皮肤黑色素生成的组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114129489A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300433A (zh) * | 2022-09-16 | 2022-11-08 | 湖北马应龙生物科技有限公司 | 一种具有美白修护功效的眼膜精华液及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101589119B1 (ko) * | 2015-04-09 | 2016-01-28 | 김인숙 | 안면 피부 온도를 낮추어 미백 효과를 내는 피부 미백용 화장료 조성물 제조 방법 |
| CN107714556A (zh) * | 2017-11-24 | 2018-02-23 | 储成玲 | 一种抗皮肤老化的面霜及其制备方法 |
| CN113208971A (zh) * | 2021-05-28 | 2021-08-06 | 深圳膜妮护肤品有限公司 | 一种美白抗皱紧致祛斑霜 |
-
2021
- 2021-12-31 CN CN202111664558.6A patent/CN114129489A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101589119B1 (ko) * | 2015-04-09 | 2016-01-28 | 김인숙 | 안면 피부 온도를 낮추어 미백 효과를 내는 피부 미백용 화장료 조성물 제조 방법 |
| CN107714556A (zh) * | 2017-11-24 | 2018-02-23 | 储成玲 | 一种抗皮肤老化的面霜及其制备方法 |
| CN113208971A (zh) * | 2021-05-28 | 2021-08-06 | 深圳膜妮护肤品有限公司 | 一种美白抗皱紧致祛斑霜 |
Non-Patent Citations (1)
| Title |
|---|
| 王雪梅等: "抗氧化活肤霜的制备及性能研究", 《香料香精化妆品》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300433A (zh) * | 2022-09-16 | 2022-11-08 | 湖北马应龙生物科技有限公司 | 一种具有美白修护功效的眼膜精华液及其制备方法和应用 |
| CN115300433B (zh) * | 2022-09-16 | 2024-02-09 | 湖北马应龙生物科技有限公司 | 一种具有美白修护功效的眼膜精华液及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111990558A (zh) | 一种吸收效果好的美白抗氧化复合果饮及其制备方法 | |
| CN103385820B (zh) | 一种修护眼霜 | |
| CN104825382A (zh) | 生物科技美白护肤品 | |
| CN113274305B (zh) | 一种即时紧致去皱美白面膜液及其制备方法和应用 | |
| CN111603434B (zh) | 一种改善皮肤皱纹的组合物及其化妆品 | |
| CN112933011B (zh) | 一种美白组合物及其制备工艺与应用 | |
| KR20130097090A (ko) | 피부 색소침착의 조절을 위한 치커리산 및 유도체의 용도 | |
| CN113693955A (zh) | 一种精华液 | |
| CN110772444A (zh) | 一种美白去皱的皮肤调理剂、面膜及其制备方法 | |
| CN112516038A (zh) | 一种抚纹逆龄胶原弹润眼霜 | |
| CN108066215A (zh) | 一种美白、抗衰老的组合物、包含其的护肤品及制备方法 | |
| CN114129489A (zh) | 一种紧致皮肤、抑制皮肤黑色素生成的组合物 | |
| CN109528615A (zh) | 一种凝胶型白及美白面膜及其制备方法 | |
| CN110559226A (zh) | 一种美白液及其制备方法 | |
| CN115212133A (zh) | 一种冻干粉溶媒液及其制备方法和应用 | |
| CN109846762B (zh) | 一种具有美白功效的组合物及其制备方法、应用 | |
| CN105055198A (zh) | 一种核桃粕淡斑美白保湿嫩肤乳及制作方法 | |
| CN113208971A (zh) | 一种美白抗皱紧致祛斑霜 | |
| CN111759762A (zh) | 祛黑眼圈组合物、精华及其制备方法 | |
| CN104800135B (zh) | 一种兼具淡斑、保湿、防晒的中药化妆品 | |
| CN111329783A (zh) | 一种即时提亮肤色的组合物及其应用 | |
| CN114869817B (zh) | 一种具有美白功效的组合物及其制备方法 | |
| CN110613672A (zh) | 一种焕颜亮肤面膜组合物、面膜及制备方法 | |
| CN109846720A (zh) | 一种撕拉型白及美白面膜及其制备方法 | |
| Ha et al. | Anti-skin aging potential of alcoholic extract of Phragmites communis rhizome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220304 |